Optical Spectroscopy for Skin Carcinomas' Surgical Management
SPECTROLIVE
Assessment of Optical Spectroscopy's Diagnosis Accuracy When Non-invasively and Automatically Classifying Skin Lesions in One of the Following Histological Classes: Healthy, Actinic Keratosis, in Situ Carcinoma and Invasive Carcinoma.
1 other identifier
interventional
142
1 country
1
Brief Summary
Actinic keratosis are of utmost medical and economical interest because of their high prevalence (20 % of 60 year-old people and older in the Northern hemisphere) and their important cosmetic impact as such actinic keratosis mostly appear on photo-exposed skin sites. The surgeon in charge of such lesions' removal (i) some actinic keratosis adjoining carcinoma to be resected therefore causing the problem of functional areas damaging (eyelids, lips, etc.) or (ii) numerous actinic keratosis localized away from carcinoma (photo-carcinogenesis field) faces the issue of clinical evaluation of such lesions: which ones will spontaneously regress (it is supposed to be the case for 20 % of such lesions);which ones will remain and which ones will develop into invasive carcinomas ? A non-invasive, non-traumatic, automated and real-time help for the clinical diagnosis orientation of such skin lesions could help improving diagnosis accuracy of the medical practitioner's visual inspection:
- In terms of sensitivity in order to potentially decrease the number of actinic keratosis evolving towards invasive carcinoma,
- In terms of specificity in order to potentially decrease useless resections and reduce resection margins and therefore reduce scars surface.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 3, 2016
CompletedFirst Posted
Study publicly available on registry
November 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 25, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 25, 2021
CompletedApril 24, 2026
April 1, 2026
4.5 years
November 3, 2016
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Optical spectroscopy's diagnostic validity for the 4 histological classes discrimination
day 1
Secondary Outcomes (3)
Statistical significance degree of the discrimination by molecular profiling (transcriptomic characterization) between in situ carcinoma (ISC) and invasive carcinoma (InvC).
day 1
Statistical significance degree of the discrimination by molecular profiling (transcriptomic characterization) between 2 classes of actinic keratosis (AK) of clinical relevance: AK characterized by a "low" versus a "high" invasiveness risk
day 1
- Sensitivity and specificity of optical spectroscopy for discriminating the é molecular classes of actinic keratosis: AK characterized by a "low" versus a "high" invasiveness risk.
day 1
Study Arms (1)
Patients - Suffering from carcinomatous or polymorphous skin
EXPERIMENTALInterventions
an optical fiber will be put in gentle contact with the patient's skin in order to acquire optical spectra
Eligibility Criteria
You may qualify if:
- Adults, and
- Autonomous: enjoying full citizenship rights and full mental abilities, and
- Affiliated to a social security system, and
- Suffering from carcinomatous or polymorphous skin lesions that can be fully managed in an outpatient (ambulatory) surgery procedure.
You may not qualify if:
- Carcinomatous or polymorphous skin lesions that require day admission, or
- Carcinomatous or polymorphous skin lesions for which resection margins are uncertain, or
- Naevomatous skin lesions and related skin pathologies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHR Metz Thionville
Metz, 57085, France
Related Publications (3)
Zghal A., Fauvel C., Kupriyanov V., Elsen T., Khairallah G., Blondel W., Amouroux M. Adv. Biomed. Clin. Diagn. Surg. Guid. Syst. XXI. SPIE; 2023. Human skin phototype and apparent age classification based on machine learning methods of autofluorescence and diffuse reflectance spectroscopic data acquired in vivo; pp. 60-64.
RESULTBlondel W., Delconte A., Khairallah G., Marchal F., Gavoille A., Amouroux M. Spatially-resolved multiply-excited autofluorescence and diffuse reflectance spectroscopy: spectrolive medical device for skin in vivo optical biopsy. Electronics. 2021;10:243. doi: 10.3390/electronics10030243.
RESULTElsen T, Fauvel C, Khairallah G, Zghal A, Delconte A, Kupriyanov V, Blondel W, Amouroux M. A dataset of optical spectra and clinical features acquired on human healthy skin and on skin carcinomas. Data Brief. 2024 Feb 6;53:110163. doi: 10.1016/j.dib.2024.110163. eCollection 2024 Apr.
PMID: 38375145RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Grégoire Khairallah
g.khairallah@chr-metz-thionville.fr
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2016
First Posted
November 7, 2016
Study Start
October 1, 2016
Primary Completion
March 25, 2021
Study Completion
March 25, 2021
Last Updated
April 24, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share